Summary by Futu AI
William Hait, EVP, Chief EI and Med Officer at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares Hait holds after the transaction also remains undisclosed.